Sectors
TENX
Tenax Therapeutics, Inc.
14.34
4 x 14.34
2 x 14.38
bid
ask
-
1.38
8.80%
01:08 PM
timesize
| Ytd | 17.61% | |
| 1y | 138.16% |
14.58
day range
16.26
5.77
52 week range
19.40
| Open | 15.92 | Prev Close | 15.72 | Low | 14.58 | High | 16.26 | Mkt Cap | 270.35M |
| Vol | 632.65K | Avg Vol | 994.24K | EPS | -1.40 | P/E | -11.23 | Forward P/E | -1.06 |
| Beta | 0.92 | Short Ratio | 1.46 | Inst. Own | 47.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 13.07 | 200-d Avg | 11.96 | 1yr Est | 16.30 |
| Income Statement | |||
| Operating Expenses | 16.57M | ||
| Research and Development Expense | 11.54M | ||
| Selling, General and Administrative Expense | 5.03M | ||
| Operating Income | -16.57M | ||
| Net Income | -15.72M | ||
| Net Income Common Stock | -15.72M | ||
| Net Income Common Stock (USD) | -15.72M | ||
| Consolidated Income | -15.72M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -15.72M | ||
| Earning Before Interest & Taxes (USD) | -15.72M | ||
| Weighted Average Shares | 45.23M | ||
| Weighted Average Shares Diluted | 45.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 118.76M | ||
| Cash and Equivalents (USD) | 118.76M | ||
| Current Assets | 123.18M | ||
| Total Assets | 123.18M | ||
| Current Liabilities | 8.49M | ||
| Total Liabilities | 8.49M | ||
| Accumulated Retained Earnings (Deficit) | -383.17M | ||
| Shareholders Equity | 114.69M | ||
| Shareholders Equity (USD) | 114.69M | ||
| Trade and Non-Trade Payables | 6.35M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 30.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.19M | ||
| Issuance (Purchase) of Equity Shares | 30.50M | ||
| Net Cash Flow from Operations | -9.31M | ||
| Share Based Compensation | 2.84M | ||